Gelonhui, March 21丨According to every report, the Changchun Hi-Tech Securities Department said that the company divested the real estate business due to comprehensive considerations of the subsidiary's actual operating situation and shareholders' voices, and there are no plans to continue divesting other businesses in the future. Furthermore, from the national policy level, the country strongly supports the traditional Chinese medicine industry. The company will continue to focus on the core biomedical business segment in the future.
长春高新拟剥离地产业务引发布局调整猜测,公司:无剥离中成药业务计划
Changchun Hi-Tech's plan to divest the real estate business has sparked speculation in the bureau's adjustments. Company: No plans to divest proprietary Chinese medicines
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.